Haemonetics (HAE) Capital Expenditures Growth (1y) (2010 - 2026)
Haemonetics (HAE) Capital Expenditures Growth (1y) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.70 Bn | 194.09 Bn | 7.27 Bn | -1.00% |
| 2 | Stryker | 129.93 Bn | 126.46 Bn | 4.50 Bn | 10.38% |
| 3 | Medtronic | 120.49 Bn | 111.27 Bn | 6.41 Bn | 6.32% |
| 4 | Boston Scientific | 74.60 Bn | 74.06 Bn | 3.85 Bn | 24.20% |
| 5 | Edwards Lifesciences | 52.68 Bn | 48.42 Bn | 1.35 Bn | 35.70% |
| 6 | Dexcom | 34.78 Bn | 32.84 Bn | 830.00 Mn | -9.99% |
| 7 | GE HealthCare Technologies | 33.83 Bn | 31.72 Bn | 2.18 Bn | 16.28% |
| 8 | Koninklijke Philips | 26.44 Bn | 23.12 Bn | 4.55 Bn | -4.32% |
| 9 | Steris | 23.18 Bn | 22.69 Bn | 684.20 Mn | -6.52% |
| 10 | Haemonetics | 4.93 Bn | 4.70 Bn | 202.80 Mn | 110.60% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 27, 2026 | 110.60% |
| Mar 28, 2026 | 12.90% |
| Dec 27, 2025 | -25.71% |
| Sep 27, 2025 | -46.82% |
| Jun 28, 2025 | -33.63% |
| Mar 29, 2025 | 134.00% |
| Dec 28, 2024 | -41.65% |
| Sep 28, 2024 | 3.51% |
| Jun 29, 2024 | -26.36% |
| Mar 30, 2024 | -92.82% |
| Dec 30, 2023 | -13.07% |
| Sep 30, 2023 | -74.66% |
| Jul 1, 2023 | -83.11% |
| Apr 1, 2023 | 165.00% |
| Dec 31, 2022 | -36.81% |
| Oct 1, 2022 | 72.77% |
| Jul 2, 2022 | 226.65% |
| Apr 2, 2022 | 201.88% |
| Jan 1, 2022 | 184.47% |
| Oct 2, 2021 | 149.57% |